Treatment of Radioresistant Stem-like Esophageal Cancer Cells by an Apoptotic Gene-armed, Telomerase-specific Oncolytic Adenovirus
Overview
Affiliations
Purpose: Radioresistance may be caused by cancer stem cells (CSC). Because CSCs require telomerase to proliferate, a telomerase-specific oncolytic adenoviral vector carrying apoptotic tumor necrosis factor-related apoptosis-inducing ligand and E1A gene (Ad/TRAIL-E1) may preferentially target CSCs.
Experimental Design: We established two pairs of parental and radioresistant (R) esophageal carcinoma cell lines (Seg-1, Seg-1R and TE-2, TE-2R) by fractionated irradiation. Stem cell markers were measured by Western blotting and flow cytometry. Serial sorting was used to enrich stem-like side population cells. Telomerase activity, transgene expression, antitumor activity, apoptosis induction, and viral replication were determined in vitro and/or in vivo.
Results: Expression of the stem cell markers beta-catenin, Oct3/4, and beta(1) integrin in Seg-1R cells was 29.4%, 27.5%, and 97.3%, respectively, compared with 4.8%, 14.9%, and 45.3% in Seg-1 cells (P < 0.05). SP levels in Seg-1R and TE-2R cells were 14.6% and 2.7%, respectively, compared with 3.4% and 0.3% in Seg-1 and TE-2 cells. Serial sorting of Seg-1R SP cells showed enrichment of the SP cells. Telomerase activities in Seg-1R, Seg-1R SP, and TE-2R cells were significantly higher than in Seg-1, Seg-1R non-SP, and TE-2 cells, respectively (P < 0.05). Seg-1R and TE-2R cells were more sensitive to Ad/TRAIL-E1 than parental cells. Increased Coxsackie-adenovirus receptor and elevated transgene expressions were found in the radioresistant cells. Ad/TRAIL-E1 resulted in significant tumor growth suppression and longer survival in Seg-1R-bearing mice (P < 0.05) with no significant toxicity.
Conclusion: Radioresistant cells established by fractionated irradiation display CSC-like cell properties. Ad/TRAIL-E1 preferentially targets radioresistant CSC-like cells.
Xiong W, Xie Y, Wang D, Huang X, Hao X, Liu J BMC Cancer. 2024; 24(1):1236.
PMID: 39375680 PMC: 11459825. DOI: 10.1186/s12885-024-13012-z.
Faghihkhorasani A, Dalvand A, Derafsh E, Tavakoli F, Younis N, Yasamineh S Cancer Cell Int. 2023; 23(1):250.
PMID: 37880659 PMC: 10599042. DOI: 10.1186/s12935-023-03099-y.
An J, Hu X, Liu F Front Oncol. 2023; 13:1114621.
PMID: 36910604 PMC: 9996315. DOI: 10.3389/fonc.2023.1114621.
The lipid rafts in cancer stem cell: a target to eradicate cancer.
Zhang S, Zhu N, Li H, Gu J, Zhang C, Liao D Stem Cell Res Ther. 2022; 13(1):432.
PMID: 36042526 PMC: 9429646. DOI: 10.1186/s13287-022-03111-8.
Induction and assessment of persistent radioresistance in murine leukocytes .
Morales-Ramirez P, Cruz-Vallejo V, Vallarino-Kelly T, Rodriguez-Reyes R, Gonzalez-Beltran F Biochem Biophys Rep. 2022; 31:101296.
PMID: 35707716 PMC: 9189778. DOI: 10.1016/j.bbrep.2022.101296.